The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Shuang LuChenglong WangYun LiuFuning ChuZhengyan JiaHongkai ZhangZhaoqi WangYanan LuShuting WangGuang YangJin-Rong QuPublished in: European radiology (2023)
• The MRI radiomics features based on T2WI-TSE-BLADE could potentially predict the pathologic response to NACT among ESCC patients. • The Delta-model exhibited the best predictive ability for pathologic response, followed by the Post-model, which similarly had better predictive ability, while the Pre-model performed less well in predicting TRG.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- rectal cancer
- contrast enhanced
- squamous cell carcinoma
- lymph node
- sentinel lymph node
- magnetic resonance imaging
- end stage renal disease
- radiation therapy
- phase ii study
- lymph node metastasis
- chronic kidney disease
- newly diagnosed
- diffusion weighted imaging
- peritoneal dialysis
- magnetic resonance
- clinical trial
- patient reported
- open label
- study protocol